癌变·畸变·突变 ›› 2005, Vol. 17 ›› Issue (2): 122-124.doi: 10.3969/j.issn.1004-616x.2005.02.017

• 肿瘤防治 • 上一篇    下一篇

40例男性乳腺癌随访资料分析

沈兴华   

  1. 浙江嘉兴学院医学院， 浙江　嘉兴　314001
  • 收稿日期:2004-08-02 修回日期:2004-09-23 出版日期:2005-03-30 发布日期:2005-03-30
  • 通讯作者: 沈兴华

Analysis of Follow-up Data for 40 Cases with Male Breast Cancer

SHEN Xing-hua   

  1. Medical College, Jiaxing University，Jiaxing Zhejiang 314001,China
  • Received:2004-08-02 Revised:2004-09-23 Online:2005-03-30 Published:2005-03-30
  • Contact: SHEN Xing-hua

PDF

2435

摘要： 背景与目的： 探讨男性乳腺癌的临床特点，治疗方法和影响预后的因素。 材料与方法： 回顾性总结40例男性乳腺癌的临床特点和治疗方法，分析其影响预后的因素。 结果： 全部病例经手术后病理检查确诊。全组患者治疗后的5、10年生存率分别为65 ％、52.5 ％。根治术与改良根治术患者的5、10年生存率分别为72.2 ％、71.4 ％。腋窝部淋巴结转移率为62.5 ％。 结论： 男性乳腺癌比女性病程长，更具有激素依赖性。容易发生腋窝淋巴结转移，预后较差。治疗上首选改良根治术并根据不同情况辅以放疗、化疗和内分泌治疗。

关键词: 乳腺肿瘤, 癌, 男性乳腺癌

Abstract: BACKGROUND ＆ AIM： To explore the clinical characterictics and the treatment and the factors affecting prognosis of male breast cancer. MATERIAL AND METHODS： The clinical data of 40 cases of male breast cancer were reviewed retrospectively, to analyze the factors affecting prognosis. RESULTS： All cases were diagnosed by pathological examination after surgery. The 5 and 10 years survival rates were 65 ％ and 52.5 ％ for all patients respectively. The 5 and 10 years survival rates were 72.2 ％ and 71.4％ for patients undergone radical mastectomy and modifed radical surgery. The axillary lymph nodes metastasis rate was 62.5 ％. CONCLUSION： Male breast cancer has longer course than female, It is characterized by hormone dependent, high metastasis rate and poor prognosis. The optimal treatment for male breast cancer is modified radical mastectomy combined with radiotherapy, chemotherapy and endocrine therapy.

Key words: breast tumor, cancer, male breast cancer

版权所有 ©2019 《癌变·畸变·突变》编辑部 E-mail： office@egh.net.cn
本系统由北京玛格泰克科技发展有限公司设计开发 技术支持：support@magtech.com.cn
粤ICP备 10216025号